Where do biomarkers fit into the diagnosis of Alzheimer’s disease? That’s the question we asked of three eminent Alzheimer’s disease researchers and clinicians: Constantine Lyketsos, MD, MHS, of Johns Hopkins University; Marc Gordon, MD, of Zucker Hillside Hospital in Glen Oaks, N.Y.; andWilliam Klunk, MD, PhD, of the University of Pittsburgh Medical Center. Their answers ranged from the here-and-now of PET scans to future possibilities such as blood tests.
Watch the video here! http://www.medpagetoday.com/HOTTOPICSNeurology/Neurology-Videos/442